Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 3202.50% is 858% above its 5-year average of -422.46%, near the high end of its 5-year range (-1565.32%–3202.50%).
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
3202.50%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
-422.46%
NET PROFIT MARGIN AVG 10Y
-492.30%
NET PROFIT MARGIN AVG 15Y
-351.22%
NET PROFIT MARGIN AVG 20Y
-201.89%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
+858.05%
CURRENT VS 10Y AVG
+750.52%
CURRENT VS 15Y AVG
+1011.82%
CURRENT VS 20Y AVG
+1686.29%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+1231830.77%
vs the sector median at left
Oramed Pharmaceuticals Inc.
Market Cap
$179.26M
Net Profit Margin
3202.50%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-422.46%
Market Cap
$179.75M
Net Profit Margin
0.00%
TTM Avg
-2904.41%
3Y Avg
-1452.20%
5Y Avg
-968.14%
Market Cap
$180.47M
Net Profit Margin
-6559.27%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$182.60M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$174.27M
Net Profit Margin
-3881.54%
TTM Avg
-6298.52%
3Y Avg
-6043.31%
5Y Avg
-5544.50%
Market Cap
$173.76M
Net Profit Margin
-229.20%
TTM Avg
-206.03%
3Y Avg
-659.07%
5Y Avg
-1951.89%
Market Cap
$172.42M
Net Profit Margin
-19.76%
TTM Avg
3.38%
3Y Avg
2.83%
5Y Avg
6.10%
Market Cap
$171.13M
Net Profit Margin
-117.04%
TTM Avg
-61.51%
3Y Avg
-173.42%
5Y Avg
-194.84%
Market Cap
$169.53M
Net Profit Margin
-8.95%
TTM Avg
-22.31%
3Y Avg
-22.43%
5Y Avg
-24.59%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. (ORMP) | $179.26M | 3202.50% | 0.00% | 0.00% | -422.46% |
| Compass Therapeutics, Inc. (CMPX)vs › | $179.75M | 0.00% | -2904.41% | -1452.20% | -968.14% |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.47M | -6559.27% | 0.00% | 0.00% | 0.00% |
| AN2 Therapeutics, Inc. (ANTX)vs › | $182.60M | 0.00% | 0.00% | 0.00% | 0.00% |
| Yarrow Bioscience Inc (YARW)vs › | $174.27M | -3881.54% | -6298.52% | -6043.31% | -5544.50% |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | -229.20% | -206.03% | -659.07% | -1951.89% |
| Organogenesis Holdings Inc. (ORGO)vs › | $172.42M | -19.76% | 3.38% | 2.83% | 6.10% |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | -117.04% | -61.51% | -173.42% | -194.84% |
| Journey Medical Corporation (DERM)vs › | $169.53M | -8.95% | -22.31% | -22.43% | -24.59% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.11M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-754.4%
Net Profit Margin
3202.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | -382.10% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | -177.15% |
| 2023-03-31 | -269.97% |
| 2022-12-31 | -1254.48% |
| 2022-09-30 | -1063.49% |
| 2022-06-30 | -1562.76% |
| 2022-03-31 | -1565.32% |
| 2021-11-30 | -1170.62% |
| 2021-08-31 | -1003.37% |
| 2021-05-31 | -764.61% |
| 2021-02-28 | -692.93% |
| 2020-11-30 | -826.41% |
| 2020-08-31 | -439.94% |
| 2020-05-31 | -335.39% |
| 2020-02-29 | -547.18% |
| 2019-11-30 | -377.30% |
| 2019-08-31 | -334.80% |
| 2019-05-31 | -597.07% |
| 2019-02-28 | -555.71% |
| 2018-11-30 | -638.28% |
| 2018-08-31 | -474.23% |
| 2018-05-31 | -705.67% |
| 2018-02-28 | -482.78% |
| 2017-11-30 | -414.24% |
| 2017-08-31 | -436.25% |
| 2017-05-31 | -318.48% |
| 2017-02-28 | -520.95% |
| 2016-11-30 | -432.13% |
| 2016-08-31 | -1348.44% |
| 2016-05-31 | -1224.54% |
| 2016-02-29 | -1454.40% |
| 2015-11-30 | -294.33% |
| 2015-08-31 | 0.00% |
| 2015-05-31 | 0.00% |
| 2015-02-28 | 0.00% |
| 2014-11-30 | 0.00% |
| 2014-08-31 | 0.00% |
| 2014-05-31 | -482.28% |
| 2014-02-28 | 0.00% |
| 2013-11-30 | 0.00% |
| 2013-08-31 | 0.00% |
| 2013-05-31 | 0.00% |
| 2013-02-28 | 0.00% |
| 2012-11-30 | 0.00% |
| 2012-08-31 | 0.00% |
| 2012-05-31 | 0.00% |
| 2012-02-29 | -2285.67% |
| 2011-11-30 | 0.00% |
| 2011-08-31 | 0.00% |
| 2011-05-31 | 0.00% |
| 2011-02-28 | 0.00% |
| 2010-11-30 | 0.00% |
| 2010-08-31 | 0.00% |
| 2010-05-31 | 0.00% |
| 2010-02-28 | 0.00% |
| 2009-11-30 | 0.00% |
| 2009-08-31 | 0.00% |
| 2009-05-31 | 0.00% |
| 2009-02-28 | 0.00% |
| 2008-11-30 | 0.00% |
| 2008-08-31 | 0.00% |
| 2008-05-31 | 0.00% |
| 2008-02-29 | 0.00% |
| 2007-11-30 | 0.00% |
| 2007-08-31 | 0.00% |
| 2007-05-31 | 0.00% |
| 2007-02-28 | 0.00% |
| 2006-11-30 | 0.00% |
| 2006-08-31 | 0.00% |
| 2006-05-31 | 0.00% |
| 2006-02-28 | 0.00% |
| 2005-11-30 | 0.00% |
| 2005-08-31 | 0.00% |
| 2005-05-31 | 0.00% |
| 2004-02-29 | 0.00% |
| 2003-11-30 | 0.00% |
| 2003-08-31 | 0.00% |
| 2003-05-31 | 0.00% |
